Anika Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Anika Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2010 to Q3 2024.
  • Anika Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 14.8M shares, a 0.91% increase year-over-year.
  • Anika Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 14.7M shares, a 0.65% increase from 2022.
  • Anika Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 14.6M shares, a 1.11% increase from 2021.
  • Anika Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 14.4M shares, a 1.26% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 14.8M +133K +0.91% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q2 2024 14.8M +151K +1.03% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 14.7M +45K +0.31% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 14.7M +95K +0.65% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-15
Q3 2023 14.6M +32K +0.22% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 14.7M +133K +0.91% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 14.7M +187K +1.29% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 14.6M +160K +1.11% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-15
Q3 2022 14.6M +174K +1.21% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 14.6M +162K +1.13% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 14.5M +123K +0.86% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 14.4M +179K +1.26% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-15
Q3 2021 14.4M +224K +1.58% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 14.4M +194K +1.37% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 14.3M +141K +0.99% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 14.2M +101K +0.72% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-16
Q3 2020 14.2M +135K +0.96% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 14.2M +283K +2.03% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 14.2M +17K +0.12% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 14.1M -321K -2.22% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-11
Q3 2019 14.1M -167K -1.17% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 13.9M -736K -5.02% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 14.2M -494K -3.37% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-22
Q4 2018 14.4M -133K -0.92% Oct 1, 2018 Dec 31, 2018 10-K/A 2021-04-26
Q3 2018 14.2M -342K -2.35% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-28
Q2 2018 14.7M +64K +0.44% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-26
Q1 2018 14.7M +103K +0.71% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-06
Q4 2017 14.6M -107K -0.73% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-06
Q3 2017 14.6M -46K -0.32% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-26
Q2 2017 14.6M -91K -0.62% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-31
Q1 2017 14.6M -299K -2.01% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 14.7M -252K -1.69% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 14.6M -342K -2.29% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-27
Q2 2016 14.7M -282K -1.89% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-28
Q1 2016 14.9M -30K -0.2% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 14.9M +256K +1.74% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-27
Q3 2015 15M +208K +1.41% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-01
Q2 2015 15M +273K +1.86% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-01
Q1 2015 14.9M +444K +3.07% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-03
Q4 2014 14.7M +405K +2.84% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-24
Q3 2014 14.8M +1.08M +7.87% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-03
Q2 2014 14.7M +1.18M +8.71% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-04
Q1 2014 14.5M +1.05M +7.87% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-04
Q4 2013 14.3M +948K +7.11% Oct 1, 2013 Dec 31, 2013 10-K 2014-03-13
Q3 2013 13.7M +395K +2.97% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 13.5M +249K +1.87% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-04
Q1 2013 13.4M +244K +1.86% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-05
Q4 2012 13.3M +203K +1.55% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-13
Q3 2012 13.3M +470K +3.66% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-13
Q2 2012 13.3M +537K +4.22% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-13
Q1 2012 13.2M +474K +3.74% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-13
Q4 2011 13.1M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-14
Q3 2011 12.8M +185K +1.46% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-14
Q2 2011 12.7M +79.3K +0.63% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-14
Q1 2011 12.7M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-14
Q3 2010 12.6M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-04
Q2 2010 12.6M Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.